March 4, 2021 1:13 AM
Latest:
  • Relay Medical Acquires Cybersecurity Firm Cybeats Technology
  • Lucid Motors SPAC A Potential Red Flag For Valuations In The Electric Vehicle Industry
  • Kirkland Lake Gold: Analysts Reiterate Targets Following Financing Results
  • Rob McEwen: Electrification Of The World Needs Metal And Mining – The Daily Dive
  • Rocket Companies Inc Shares Soar by Over 70% as WallStreetBets Continue to Squeeze Hedge Funds
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Cannabis
      • Pure Extracts
      • Tinley Beverage Co
    • Mining
      • AUX Resources
      • Freeman Gold
      • Newlox Gold Ventures
      • Noram Ventures
      • Riverside Resources
      • SKRR Exploration Inc.
      • Spruce Ridge Resources
    • Technology
      • CloudMD
      • Datametrex AI Limited
      • MustGrow Biologics
      • PowerBand Solutions
      • Revive Therapeutics
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Mind Medicine

Briefing Psychedelics Technology 

MindMed Acquires HealthMode For $41.6 Million

February 18, 2021 8:21 AMFebruary 18, 2021 8:21 AM Jay Lutz 0 Comments Mind Medicine, MindMed

MindMed (NEO: MMED) this morning announced that it will be acquiring that of HealthMode in a largely stock-based transaction. HealthMode

Share
Tweet
Share
Read more
Briefing Psychedelics 

MindMed Begins Study On LSD Neutralizer Technology

February 17, 2021 8:18 AMFebruary 17, 2021 8:19 AM Jay Lutz 0 Comments Mind Medicine, MindMed

MindMed (NEO: MMED) this morning announced that it has begun a study on what it refers to as “LSD neutralizer

Share
Tweet
Share
Read more
Briefing Psychedelics 

MindMed Launches Clinical Trial Focused On Combining LSD With MDMA

January 20, 2021 8:09 AMJanuary 20, 2021 8:10 AM Jay Lutz 1 Comment Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has begun the first clinical trials focused on combining MDMA and LSD. The trials, to be

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Raises $92.1 Million Via Bought Deal Financing

January 7, 2021 9:31 AMJanuary 7, 2021 9:32 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has closed its previously announced bought deal financing, raising nearly double the initial $50.0 million the

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Announces $50 Million Bought Deal Financing Days After Raising $34.5 Million

December 14, 2020 8:43 PMDecember 14, 2020 8:44 PM Jay Lutz 0 Comments Mind Medicine

Mind Medicine (NEO: MMED) is raising even more cash. The company this evening announced that they have agreed to conduct

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Completes Pre-IND Meeting For LSD Assisted Therapy In Anxiety

December 14, 2020 7:54 AMDecember 14, 2020 7:54 AM Jay Lutz 0 Comments Mind Medicine

Mind Medicine (NEO: MMED) this morning issued a brief update related two products within its research pipeline. Firstly, the company

Share
Tweet
Share
Read more
Briefing Psychedelics 

MindMed Closes $34.5 Million Financing, Cash Reserves Said To Be At $85 Million

December 11, 2020 9:15 AMDecember 11, 2020 9:15 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has completed its previously announced bought deal private placement, raising gross proceeds of $34.5 million. The

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Returns To Trough For Further $25.0 Million

November 25, 2020 9:25 AMNovember 25, 2020 9:25 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) continues to take investor dollars, this morning announcing a bought deal private placement for $25.0 million.

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine: Canaccord Maintains Ratings Following Financial Results

November 17, 2020 10:17 AMNovember 17, 2020 10:02 AM Justin Young 0 Comments Analyst Estimate, Mind Medicine, MindMed

On Friday, November 13th, Mind Medicine (NEO: MMED) reported their third quarter 2020 financial results. Tania Gonsalves, Canaccord Genuity’s biotechnology

Share
Tweet
Share
Read more
Briefing Psychedelics 

Canaccord Raises Mind Medicine’s Price Target To $2.00 Following Financing

November 2, 2020 10:45 AMNovember 2, 2020 10:50 AM Justin Young 2 Comments Analyst Estimate, Mind Medicine, MindMed

This morning, Canaccord Genuity raised its 12-month price target on Mind Medicine (NEO: MMED) from C$1.75 to C$2.00 while reiterating

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Relay Medical Acquires Cybersecurity Firm Cybeats Technology
Briefing News Technology 

Relay Medical Acquires Cybersecurity Firm Cybeats Technology

March 3, 2021 4:49 PM Jay Lutz 0

Relay Medical (CSE: RELA) this evening announced that it is looking to strengthen its cybersecurity abilities. The company is acquiring

Lucid Motors SPAC A Potential Red Flag For Valuations In The Electric Vehicle Industry
Automotive Briefing SPACs 

Lucid Motors SPAC A Potential Red Flag For Valuations In The Electric Vehicle Industry

March 3, 2021 3:50 PM Jim McFadden 0
Kirkland Lake Gold: Analysts Reiterate Targets Following Financing Results
Briefing Resources 

Kirkland Lake Gold: Analysts Reiterate Targets Following Financing Results

March 3, 2021 2:50 PM Justin Young 0
Rob McEwen: Electrification Of The World Needs Metal And Mining – The Daily Dive
Briefing Macro Resources Video Series 

Rob McEwen: Electrification Of The World Needs Metal And Mining – The Daily Dive

March 3, 2021 1:30 PM Jay Lutz 0
Rocket Companies Inc Shares Soar by Over 70% as WallStreetBets Continue to Squeeze Hedge Funds
Briefing Macro 

Rocket Companies Inc Shares Soar by Over 70% as WallStreetBets Continue to Squeeze Hedge Funds

March 3, 2021 11:44 AM Hermina Paull 0
Mortgage Rate Spike Threatens to Derail US Housing Boom
Bonds Briefing Macro 

Mortgage Rate Spike Threatens to Derail US Housing Boom

March 3, 2021 10:31 AM Hermina Paull 0
Columbia Care Reports Preliminary Q4 Revenues Of $76.1 Million, Provides 2021 Guidance
Briefing Cannabis 

Columbia Care Reports Preliminary Q4 Revenues Of $76.1 Million, Provides 2021 Guidance

March 3, 2021 9:38 AM Jay Lutz 0

Spotlight Series

Rob McEwen: Electrification Of The World Needs Metal And Mining – The Daily Dive
Briefing Macro Resources Video Series 

Rob McEwen: Electrification Of The World Needs Metal And Mining – The Daily Dive

March 3, 2021 1:30 PM Jay Lutz 0

Today on the Daily Dive, our host Cassandra Leah sits down with famed Canadian businessman Rob McEwen, Chairman and Chief

News

Relay Medical Acquires Cybersecurity Firm Cybeats Technology
Briefing News Technology 

Relay Medical Acquires Cybersecurity Firm Cybeats Technology

March 3, 2021 4:49 PM Jay Lutz 0

Relay Medical (CSE: RELA) this evening announced that it is looking to strengthen its cybersecurity abilities. The company is acquiring

Exploits Discovery Announces 4,500 Metre Drill Program For Dog Bay Property
Briefing News Resources 

Exploits Discovery Announces 4,500 Metre Drill Program For Dog Bay Property

March 3, 2021 9:24 AM Jay Lutz 0
MustGrow Biologics Isolates Third Molecule From Mustard Plant
Biotech Briefing News 

MustGrow Biologics Isolates Third Molecule From Mustard Plant

March 3, 2021 8:46 AM Jay Lutz 0
Mind Cure Health Begins Manufacturing Synthetic Ibogaine
Briefing News Psychedelics 

Mind Cure Health Begins Manufacturing Synthetic Ibogaine

March 3, 2021 8:03 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Need some freelance work done? We’re experienced in many forms of writing, including press releases. Shoot us an email & let’s chat!

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Psychedelics
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2021 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.